Suppr超能文献

富含亮氨酸的α-2糖蛋白是肾小管损伤的一种潜在尿液生物标志物。

Leucine rich α-2 glycoprotein is a potential urinary biomarker for renal tubular injury.

作者信息

Lee Hyun, Fujimoto Minoru, Ohkawara Tomoharu, Honda Hiromi, Serada Satoshi, Terada Yoshio, Naka Tetsuji

机构信息

Graduate School of Frontier Biosciences, Osaka University, Suita, Osaka 565-0871, Japan; Center for Intractable Immune Disease, Kochi Medical School, Kochi University, Nankoku, Kochi 783-8505, Japan.

Center for Intractable Immune Disease, Kochi Medical School, Kochi University, Nankoku, Kochi 783-8505, Japan.

出版信息

Biochem Biophys Res Commun. 2018 Apr 15;498(4):1045-1051. doi: 10.1016/j.bbrc.2018.03.111. Epub 2018 Mar 17.

Abstract

Recent evidence suggests that renal tubular injury plays a key role in deterioration of renal function in both chronic kidney disease (CKD) and acute kidney injury (AKI). Since commonly used biochemical indicators such as GFR, serum creatinine, blood urea nitrogen and creatinine clearance are inappropriate for detecting alteration in renal tubules, biomarkers reflecting renal tubular injury have been extensively explored. Our research group identified leucine rich α-2 glycoprotein (LRG) as a novel serum biomarker for various inflammatory diseases such as rheumatoid arthritis and inflammatory bowel disease. In inflammatory diseases, LRG expression is up-regulated at the site of inflammation, in accordance with the induction of LRG in many cell types by various inflammatory cytokines. Recently, urinary LRG was reported as a possible biomarker for several renal diseases, but the mechanism of LRG excretion in urine is still unclear. In this study, by analyzing a mouse albumin (ALB) overload model that is commonly used to study proteinuria-induced renal tubular injury, we provided evidence that urinary LRG is produced in renal tubular epithelial cells by interleukin-1β (IL-1β) that is released during proteinuria-induced renal damage. In this model, urinary LRG became detectable after ALB overload. In kidney, mRNA expression of LRG together with that of NACHT LRR and PYD domains-containing protein 3 (NLRP3) and IL-1β was significantly up-regulated in ALB-overloaded mice, compared to PBS-treated mice. By pathological analysis of kidney, LRG was detected in the injured proximal tubules, distal tubules and collecting ducts in ALB-overloaded mice. Accordingly, in vitro stimulation of mouse renal cortical tubular epithelial cells with excessive ALB led to LRG mRNA up-regulation and its protein secretion, which was effectively blocked by IL-1 receptor antagonist. These results suggest that urinary LRG could be applied to a biomarker detecting renal tubular injury in various renal diseases.

摘要

最近的证据表明,肾小管损伤在慢性肾脏病(CKD)和急性肾损伤(AKI)的肾功能恶化中起关键作用。由于常用的生化指标如肾小球滤过率(GFR)、血清肌酐、血尿素氮和肌酐清除率不适用于检测肾小管的改变,反映肾小管损伤的生物标志物已被广泛探索。我们的研究小组将富含亮氨酸的α-2糖蛋白(LRG)鉴定为类风湿关节炎和炎症性肠病等各种炎症性疾病的新型血清生物标志物。在炎症性疾病中,LRG的表达在炎症部位上调,这与多种炎症细胞因子在许多细胞类型中诱导LRG的情况一致。最近,尿LRG被报道为几种肾脏疾病的可能生物标志物,但LRG在尿液中排泄的机制仍不清楚。在本研究中,通过分析常用于研究蛋白尿诱导的肾小管损伤的小鼠白蛋白(ALB)过载模型,我们提供了证据表明,尿LRG是由蛋白尿诱导的肾损伤期间释放的白细胞介素-1β(IL-1β)在肾小管上皮细胞中产生的。在该模型中,ALB过载后尿LRG变得可检测到。在肾脏中,与用磷酸盐缓冲盐水(PBS)处理的小鼠相比,ALB过载小鼠中LRG以及含NACHT亮氨酸重复序列和PYD结构域蛋白3(NLRP3)和IL-1β的mRNA表达显著上调。通过肾脏病理分析,在ALB过载小鼠的受损近端小管、远端小管和集合管中检测到LRG。因此,用过量ALB体外刺激小鼠肾皮质肾小管上皮细胞导致LRG mRNA上调及其蛋白分泌,这被IL-1受体拮抗剂有效阻断。这些结果表明,尿LRG可作为检测各种肾脏疾病中肾小管损伤的生物标志物。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验